Hypertonic saline (7.5%) after coronary artery bypass grafting

被引:19
作者
Järvelä, K [1 ]
Kaukinen, S [1 ]
机构
[1] Tampere Univ Hosp, Dept Anaesthesia & Intens Care, FIN-33521 Tampere, Finland
关键词
hypertonic solutions; saline solution; hypertonic; myocardial revascularisation; coronary artery bypass; haemodynamics; blood volume;
D O I
10.1046/j.0265-0215.2000.00788.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background and objective Patients undergoing coronary artery bypass grafting often require volume loading after operation. In this situation hypertonic saline may be beneficial in restoring the haemodynamic balance and removing excess extravascular fluid. Methods Forty coronary artery bypass grafting patients were randomly assigned to receive either hypertonic saline 7.5% (20 patients) or 0.9% saline (20 patients) as a single dose of 4 mt kg(-1) over 30 min in the postoperative rewarming phase in the intensive care unit. Results Mean arterial pressure increased in the hypertonic saline group from 82 +/- 10 (SD) to 104 +/- 17 mmHg (P=0.002 vs. the normal saline group), and the cardiac index rose from 2.3+/-0.5 to 3.4+/-0.8 L min(-1) m(2) (P=0.002 vs. the normal group). The haemodynamic effect of hypertonic saline lasted only about 1 h. Diuresis was greater in the hypertonic saline group both at Ih (hypertonic saline. 490 +/- 274 vs, normal sai;np 204+/-130 mL; P=0.001) and 10 h (hypertonic saline: 1952 +/- 554 vs, normal saline: 1421 =/- 514 mt; P = 0.003). Conclusions No adverse effects were seen. The hyper tonic saline had a strong diuretic effect and may be beneficial in coronary artery bypass graft patients after operations. This is because of its value as a short-term plasma expander and the diuresis eliminates excessive fluid from the body. A larger study is needed to determine whether the benefits outweigh the possible side-effects in these patients.
引用
收藏
页码:100 / 107
页数:8
相关论文
共 33 条
[1]  
AULER JOC, 1987, SURGERY, V101, P594
[2]   THE BLOOD-VOLUME AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM FOLLOWING OPEN-HEART SURGERY [J].
BARTA, E ;
KUZELA, L ;
TORDOVA, E ;
HORECKY, J ;
BABUSIKOVA, F .
RESUSCITATION, 1980, 8 (02) :137-146
[3]  
BITTERMAN H, 1987, CIRC SHOCK, V21, P271
[4]   RETRACTED: CARDIORESPIRATORY RESPONSES TO HYPERTONIC SALINE SOLUTION IN CARDIAC OPERATIONS (Retracted article. See vol. 111, 2021) [J].
BOLDT, J ;
ZICKMANN, B ;
BALLESTEROS, M ;
HEROLD, C ;
DAPPER, F ;
HEMPELMANN, G .
ANNALS OF THORACIC SURGERY, 1991, 51 (04) :610-615
[5]   HYPERTONIC SALINE FLUID THERAPY FOLLOWING SURGERY - A PROSPECTIVE-STUDY [J].
CROSS, JS ;
GRUBER, DP ;
BURCHARD, KW ;
SINGH, AK ;
MORAN, JM ;
GANN, DS .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1989, 29 (06) :817-826
[6]  
CRYSTAL GJ, 1994, CIRC SHOCK, V42, P27
[7]   CONTINUOUS BLOOD DENSITY-MEASUREMENTS AND VOLUME CHANGES DURING EXTRACORPOREAL-CIRCULATION IN PATIENTS UNDERGOING CARDIAC-SURGERY [J].
DACAR, D .
THORACIC AND CARDIOVASCULAR SURGEON, 1995, 43 (01) :13-18
[8]  
DEFILIPPE J, 1980, LANCET, V2, P1002
[9]   EFFECTS OF AN ACUTE SALINE INFUSION ON FLUID AND ELECTROLYTE METABOLISM IN HUMANS [J].
DRUMMER, C ;
GERZER, R ;
HEER, M ;
MOLZ, B ;
BIE, P ;
SCHLOSSBERGER, M ;
STADAEGER, C ;
ROCKER, L ;
STROLLO, F ;
HEYDUCK, B ;
BAUER, K ;
WARBERG, J ;
BAISCH, F ;
CHRISTENSEN, NJ ;
KONIG, A ;
NORSK, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (05) :F744-F754
[10]   OPTIMAL PREOPERATIVE TITRATED DOSAGE OF HYPERTONIC HYPERONCOTIC SOLUTIONS IN CARDIAC RISK PATIENTS [J].
ELLINGER, K ;
FAHNLE, M ;
SCHROTH, M ;
ALBRECHT, DM .
SHOCK, 1995, 3 (03) :167-172